Factors | No. patients | Hazard ratio | 95% CI | p-value |
---|---|---|---|---|
Age |  | 0.506 | 0.146–1.749 | 0.273 |
≤ 60 | 37 |  |  |  |
> 60 | 20 |  |  |  |
Menopause at diagnosis |  | 0.591 | 0.153–2.289 | 0.442 |
No | 23 | Â | Â | Â |
Yes | 34 | Â | Â | Â |
Histological subtype |  | 0.696 | 0.148–3.280 | 0.645 |
Serous | 48 | Â | Â | Â |
Non-serous | 9 | Â | Â | Â |
FIGO Stage |  | 0.031 | 0.004–0.248 | p < 0.01 |
I/II | 41 | Â | Â | Â |
III | 16 | Â | Â | Â |
Grade | Â | 0.046 | 0.000-6148.234 | 0.436 |
I/II | 3 | Â | Â | Â |
III/unkown | 54 | Â | Â | Â |
Preoperative serum CA 125, U/mL |  | 0.02 | 0.000-3.610 | p < 0.01 |
< 35 | 22 |  |  |  |
≥ 35 | 35 |  |  |  |
Residual tumor size at initial surgery (cm) | Â | Â | 0.030 | |
0 | 53 | Â | Â | Â |
> 0,≤1 | 2 | 0.117 | 0.024–0.570 |  |
> 1 | 2 | 0.655 | 0.059–7.285 |  |
Tumor diameter (cm) |  | 0.495 | 0.105–2.330 | 0.364 |
< 5 | 19 |  |  |  |
≥ 5 | 38 |  |  |  |
Lymphadenectomy |  | 5.539 | 1.429–21.466 | 0.050 |
No | 5 | Â | Â | Â |
Yes | 52 | Â | Â | Â |
Omentectomy | Â | 0.04 | 0.000-112.275 | 0.214 |
No | 7 | Â | Â | Â |
Yes | 50 | Â | Â | Â |
Appendectomy |  | 0.285 | 0.080–1.010 | 0.038 |
No | 47 | Â | Â | Â |
Yes | 10 | Â | Â | Â |
Chemotherapy (courses) |  | 0.083 | 0.023–0.301 | p < 0.01 |
≤ 6 | 53 |  |  |  |
> 6 | 4 |  |  |  |